ARTICLE | Tools & Techniques
Atomwise's JV spree
How Atomwise’s partners are thinking about deal structure for AI-driven chemistry
September 19, 2019 10:21 PM UTC
Drug developers signing up to partner with Atomwise for hit discovery and lead optimization said deal structures made it attractive to take the plunge on the AI company's emerging technology.
Last week, Atomwise Inc. announced three JVs with U.S.-based cancer companies and a collaboration with Chinese pharma Hansoh Pharmaceutical Group Co. Ltd. (HKEX:03692). In the last year, Atomwise has also announced partnerships with Pfizer Inc. (NYSE:PFE), Charles River Laboratories International Inc. (NYSE:CRL) and Eli Lilly and Co. (NYSE:LLY)...